RNS
ADVM

Robert N. Shapiro’s Adverum Biotechnologies ADVM Stock Holding History

Robert N. Shapiro’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$6K Buy
+10
New +$3.85K ﹤0.01% 729

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCP
Tourbillon Capital Partners New York $6.26M AUM 42.29% 1-Year Est. Return

Robert N. Shapiro's ADVM Position: Q4 2014 in Review

Robert N. Shapiro opened a new position in Adverum Biotechnologies (ADVM) in Q4 2014: 10 shares worth $6K. The stake represents ﹤0.01% of the portfolio and ranks #729 among its holdings.

84 funds tracked by Wall St. Rank hold ADVM as of Q4 2014.

  • Robert N. Shapiro held 10 shares of Adverum Biotechnologies worth $6K as of Q4 2014.
  • Adverum Biotechnologies was a new Robert N. Shapiro position in Q4 2014.
  • Adverum Biotechnologies made up ﹤0.01% of Robert N. Shapiro's portfolio in Q4 2014, its #729 holding.
  • 84 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2014.

Based on Robert N. Shapiro's 13F filing for Q4 2014, filed 19 Feb 2015.